Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia

American Journal of Physiology - Renal Physiology

Volumn 309, Issue 8, 2015, Pages F744-F754

  Yamada, Shunsuke ^a,b   Tokumoto, Masanori ^a   Tsuruya, Kazuhiko ^b   Tatsumoto, Narihito ^b   Noguchi, Hideko ^b   Kitazono, Takanari ^b   Ooboshi, Hiroaki ^a  

^a FUKUOKA DENTAL COLLEGE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Fetuin A; Inflammation; Low protein diet; Malnutrition; Vascular calcification

Indexed keywords

ADENINE; ALBUMIN; CALCITRIOL; CALCIUM; CALCIUM PHOSPHATE; FETUIN A; FIBROBLAST GROWTH FACTOR 23; INTERLEUKIN 1BETA; PHOSPHATE; SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA; ALBUMINOID; PHOSPHATE INTAKE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL CALCIFICATION; BODY WEIGHT; CALCIUM BLOOD LEVEL; CELL CULTURE; CHEMICAL PARAMETERS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CREATININE URINE LEVEL; DIET SUPPLEMENTATION; FETAL CALF SERUM; FOOD INTAKE; HYPERPHOSPHATEMIA; INFLAMMATION; LIVER PARENCHYMA; MALE; MALNUTRITION; NONHUMAN; NUTRITIONAL STATUS; OXIDATIVE STRESS; PHOSPHATE INTAKE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; PROTEIN RESTRICTION; PROTEIN SYNTHESIS; RAT; UREMIA; URINALYSIS; URINARY EXCRETION; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; COMPLICATION; DEFICIENCY; DRUG EFFECTS; METABOLISM; PHARMACOLOGY; PROTEIN CALORIE MALNUTRITION; SPRAGUE DAWLEY RAT; VASCULAR CALCIFICATION; VASCULAR SMOOTH MUSCLE;

ALBUMINS; ALPHA-2-HS-GLYCOPROTEIN; ANIMALS; CALCIUM PHOSPHATES; CELLS, CULTURED; DIET, PROTEIN-RESTRICTED; HYPERPHOSPHATEMIA; MALE; MUSCLE, SMOOTH, VASCULAR; PHOSPHORUS, DIETARY; PROTEIN-ENERGY MALNUTRITION; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; UREMIA; VASCULAR CALCIFICATION;

EID: 84944447479     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00017.2015     Document Type: Article

References (50)

1. Aghagolzadeh P, Bijarnia RK, Chandak P, Bachtler M, Smith ER, Pasch A. Calciprotein particles induce calcification of vascular smooth muscle cells in vitro. J Am Soc Nephrol 25:PO-550, 2014.
2. Anonymous. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kindey Foundation. Am J Kidney Dis 35, Suppl 2: S1–S140, 2000
3. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38: 938–942, 2001.
4. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68: 1815–1824, 2005.
5. Block GA, Ix JH, Ketteler M, Martin KJ, Thadhani RI, Tonelli M, Wolf M, Jüppner H, Hruska K, Wheeler DC. Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation. Am J Kidney Dis 62: 457–473, 2013.
6. Brylka L, Jahnen-Dechent W. The role of fetuin-A in physiological and pathological mineralization. Calcif Tissue Int 93: 355–364, 2013.
7. Dautova Y, Kozlova D, Skepper JN, Epple M, Bootman MD, Proudfoot D. Fetuin-a and albumin alter cytotoxic effects of calcium phosphate nanoparticles on human vascular smooth muscle cells. PLoS One 9: e97565, 2014.
8. Fouque D, Horne R, Cozzolino M, Kalantar-Zadeh K. Balancing nutrition and serum phosphorus in maintenance dialysis. Am J Kidney Dis 64: 143–150, 2014.
9. Gangneux C, Daveau M, Hiron M, Derambure C, Papaconstantinou J, Salier JP. The inflammation-induced down-regulation of plasma fetuin-A (alpha2HS-glycoprotein) in liver results from the loss of interaction between long C/EBP isoforms at two neighbouring binding sites. Nucleic Acids Res 31: 5957–5970, 2003.
10. Golden MH, Ramdath D. Free radicals in the pathogenesis of kwashiorkor. Proc Nutr Soc 46: 53–68, 1987.
11. Gutiérrez OM, Wolf M. Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies. Semin Dial 23: 401–406, 2010.
12. Hamano T, Matsui I, Mikami S, Tomida K, Fujii N, Imai E, Rakugi H, Isaka Y. Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 21: 1998–2007, 2010.
13. Heiss A, Jahnen-Dechent W, Endo H, Schwahn D. Structural dynamics of a colloidal protein-mineral complex bestowing on calcium phosphate a high solubility in biological fluids. Biointerphases 2: 16-20, 2007.
14. Heiss A, Eckert T, Aretz A, Richtering W, van Dorp W, Schäfer C, Jahnen-Dechent W. Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles. J Biol Chem 283: 14815–14825, 2008.
15. Herrmann M, Schäfer C, Heiss A, Gräber S, Kinkeldey A, Büscher A, Schmitt MM, Bornemann J, Nimmerjahn F, Herrmann M, Helming L, Gordon S, Jahnen-Dechent W. Clearance of fetuin-A– containing calciprotein particles is mediated by scavenger receptor-A. Circ Res 111: 575–584, 2012.
16. Isakova T, Gutiérrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf M. Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 20: 388–396, 2009.
17. Jahnen-Dechent W, Heiss A, Schäfer C, Ketteler M. Fetuin-A regulation of calcified matrix metabolism. Circ Res 108: 1494–1509, 2011.
18. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 42: 864–881, 2003.
19. Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, Kopple JD. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 5: 519–530, 2010.
20. Kapustin AN, Chatrou ML, Drozdov I, Zheng Y, Davidson SM, Soong D, Furmanik M, Sanchis P, De Rosales RT, Alvarez-Hernandez D, Shroff R, Yin X, Muller K, Skepper JN, Mayr M, Reutelingsperger CP, Chester A, Bertazzo S, Schurgers LJ, Shanahan CM. Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. Circ Res 116: 1312–1323, 2015.
21. Kuro-o M. Calciprotein particle (CPP): a true culprit of phosphorus woes? Nefrologia 34: 1–4, 2014.
22. Ling PR, Smith RJ, Kie S, Boyce P, Bistrian BR. Effects of protein malnutrition on IL-6-mediated signaling in the liver and the systemic acute-phase response in rats. Am J Physiol Regul Integr Comp Physiol 287: R801–R808, 2004.
23. Ling PR, Bistrian BR. Comparison of the effects of food versus protein restriction on selected nutritional and inflammatory markers in rats. Metabolism 58: 835–842, 2009.
24. Lynch KE, Lynch R, Curhan GC, Brunelli SM. Prescribed dietary phosphate restriction and survival among hemodialysis patients. Clin J Am Soc Nephrol 6: 620–629, 2011.
25. Martin KJ, González EA. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat? Clin J Am Soc Nephrol 6: 440–446, 2011.
26. Menon V, Kopple JD, Wang X, Beck GJ, Collins AJ, Kusek JW, Greene T, Levey AS, Sarnak MJ. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis 53: 208–217, 2009.
27. Moe SM, Reslerova M, Ketteler M, Oneill K, Duan D, Koczman J, Westenfeld R, Jahnen-Dechent W, Chen NX. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 67: 2295–2304, 2005.
28. Nadra I, Mason JC, Philippidis P, Florey O, Smythe CD, McCarthy GM, Landis RC, Haskard DO. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ Res 96: 1248–1256, 2005.
29. Newsome B, Ix JH, Tighiouart H, Sarnak MJ, Levey AS, Beck GJ, Block G. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. Am J Kidney Dis 61: 1045–1046, 2013.
30. Ohara I, Tabuchi R, Kimura M, Itokawa Y. Decline of taste sensitivity in protein deficient adult rats. Physiol Behav 57: 921–926, 1995.
31. Pazár BP, Ea HK, Narayan S, Kolly L, Bagnoud N, Chobaz V, Roger T, Lioté F, So A, Busso N. Basic calcium phosphate crystals induce monocyte/macrophage IL-1 secretion through the NLRP3 inflammasome in vitro. J Immunol 186: 2495–2502, 2011.
32. Price PA, Williamson MK, Nguyen TM, Than TN. Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. J Biol Chem 279: 1594–1600, 2004.
33. Price PA, Roublick AM, Williamson MK. Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 70: 1577–1583, 2006.
34. Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, Weissberg PL, Jahnen-Dechent W, Shanahan CM. Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 16: 2920–2930, 2005.
35. Russo D, Corrao S, Miranda I, Ruocco C, Manzi S, Elefante R, Brancaccio D, Cozzolino M, Biondi ML, Andreucci VE. Progression of coronary artery calcification in predialysis patients. Am J Nephrol 27: 152–158, 2007.
36. Sage AP, Lu J, Tintut Y, Demer LL. Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 79: 414–422, 2011.
37. Sauerwein RW, Mulder JA, Mulder L, Lowe B, Peshu N, Demacker PN, van der Meer JW, Marsh K. Inflammatory mediators in children with protein-energy malnutrition. Am J Clin Nutr 65: 1534-1539, 1997.
38. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112: 357–366, 2003.
39. Scialla JJ, Wolf M. Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nat Rev Nephrol 10: 268–278, 2014.
40. Shimomura A, Matsui I, Hamano T, Ishimoto T, Katou Y, Takehana K, Inoue K, Kusunoki Y, Mori D, Nakano C, Obi Y, Fujii N, Takabatake Y, Nakano T, Tsubakihara Y, Isaka Y, Rakugi H. Dietary L-lysine prevents arterial calcification in adenine-induced uremic rats. J Am Soc Nephrol 25: 1954–1965, 2014.
41. Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 88: 1511–1518, 2008.
42. Shuto E, Taketani Y, Tanaka R, Harada N, Isshiki M, Sato M, Nashiki K, Amo K, Yamamoto H, Higashi Y, Nakaya Y, Takeda E. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol 20: 1504–1512, 2009.
43. Smith ER, Hanssen E, McMahon LP, Holt SG. Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage. PLoS One 8: e60904, 2013.
44. Son BK, Akishita M, Iijima K, Kozaki K, Maemura K, Eto M, Ouchi Y. Adiponectin antagonizes stimulatory effect of tumor necrosis factoralpha on vascular smooth muscle cell calcification: regulation of growth arrest-specific gene 6-mediated survival pathway by adenosine 5=-monophosphate- activated protein kinase. Endocrinology 149: 1646–1653, 2008.
45. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55: 1899–1911, 1999.
46. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102: 2636–2642, 2000.
47. Yamada S, Tokumoto M, Tatsumoto N, Taniguchi M, Noguchi H, Nakano T, Masutani K, Ooboshi H, Tsuruya K, Kitazono T. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia. Am J Physiol Renal Physiol 306: F1418–F1428, 2014.
48. Yamamoto KT, Robinson-Cohen C, de Oliveira MC, Kostina A, Nettleton JA, Ix JH, Nguyen H, Eng J, Lima JA, Siscovick DS, Weiss NS, Kestenbaum B. Dietary phosphorus is associated with greater left ventricular mass. Kidney Int 83: 707–714, 2013.
49. Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, Lui SF, Li PK, Sanderson JE. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 20: 1676–1685, 2005.
50. Wilson FP, Xie D, Anderson AH, Leonard MB, Reese PP, Delafontaine P, Horwitz E, Kallem R, Navaneethan S, Ojo A, Porter AC, Sondheimer JH, Sweeney HL, Townsend RR, Feldman HI; Study Investigators CRIC. Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study. Clin J Am Soc Nephrol 9: 2095–2103, 2014.